These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3516964)

  • 1. Efficacy of cefmenoxime in experimental group B streptococcal bacteraemia and meningitis.
    Kim KS
    J Antimicrob Chemother; 1986 Feb; 17(2):239-44. PubMed ID: 3516964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.
    Kim KS; Bayer AS
    Antimicrob Agents Chemother; 1985 Jul; 28(1):51-4. PubMed ID: 3899006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.
    Kim KS
    Antimicrob Agents Chemother; 1985 Sep; 28(3):389-92. PubMed ID: 3907491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone therapy of group B streptococcal bacteraemia and meningitis in infant rats.
    Delaplane D; Yogev R; Shulman ST
    J Antimicrob Chemother; 1983 Jan; 11(1):69-73. PubMed ID: 6298176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of teicoplanin in experimental group B streptococcal bacteremia and meningitis.
    Kim KS; Hang JH; Bayer AS
    Chemotherapy; 1987; 33(3):177-82. PubMed ID: 2954777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of imipenem in experimental group B streptococcal bacteremia and meningitis.
    Kim KS
    Chemotherapy; 1985; 31(4):304-9. PubMed ID: 3896683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antimicrobial therapy for experimental infections due to group B Streptococcus on mortality and clearance of bacteria.
    Kim KS
    J Infect Dis; 1987 Jun; 155(6):1233-41. PubMed ID: 3553349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae.
    Täuber MG; Doroshow CA; Hackbarth CJ; Rusnak MG; Drake TA; Sande MA
    J Infect Dis; 1984 Apr; 149(4):568-74. PubMed ID: 6327835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental group B streptococcal endocarditis treated with penicillin G versus ceftizoxime. In vitro-in vivo disparity.
    Bayer AS; Morrison JO; Kim KS
    Chemotherapy; 1983; 29(5):352-61. PubMed ID: 6311493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of human immunoglobulin and penicillin G in treatment of experimental group B streptococcal infection.
    Kim KS
    Pediatr Res; 1987 Mar; 21(3):289-92. PubMed ID: 3550675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid penetration of cefmenoxime in children with bacterial meningitis.
    Eicken A; Schöber JG; Roos R; Machka K
    Infection; 1991; 19(6):406-8. PubMed ID: 1816111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious infection in an adult due to penicillin-tolerant group B streptococcus.
    Steinbrecher UP
    Arch Intern Med; 1981 Nov; 141(12):1714-5. PubMed ID: 7030251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS; Manocchio M; Bayer AS
    Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of penicillin to eradicate the carrier state of group B Streptococcus in infants.
    Paredes A; Wong P; Yow MD
    J Pediatr; 1976 Aug; 89(2):191-3. PubMed ID: 781199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies.
    LeFrock JL; Molavi A; McCloskey RV; Rolston K; Chandrasekar P; Henao L; Smith BR; Kannangara W; Schell RF; Carr BB
    Am J Med; 1984 Jul; 77(1):72-8. PubMed ID: 6331163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of group B streptococcal infection.
    Truog WE; Davis RF; Ray CG
    J Pediatr; 1976 Aug; 89(2):185-6. PubMed ID: 781196
    [No Abstract]   [Full Text] [Related]  

  • 17. Group B streptococcal meningitis in an intravenous drug abuser.
    Feltoon A; Glauser J
    Ann Emerg Med; 1984 Sep; 13(9 Pt 1):739-42. PubMed ID: 6380353
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of cefmenoxime in the pediatric infections].
    Meguro H; Ozawa S; Togo T; Hiraiwa M; Kim B; Fujii R
    Jpn J Antibiot; 1982 Oct; 35(10):2405-13. PubMed ID: 6306292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
    Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
    Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K; Nagatake T; Uzuka Y; Harada T; Rikitomi N
    Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.